Calumet Specialty Products Stock Investor Sentiment

CLMT Stock  USD 22.54  0.14  0.63%   
Slightly above 51% of Calumet Specialty's private investors are presently thinking to get in. The current sentiment regarding investing in Calumet Specialty Products stock implies that some traders are interested. Calumet Specialty's investing sentiment can be driven by a variety of factors including economic data, Calumet Specialty's earnings reports, geopolitical events, and overall market trends.
  

Calumet Specialty Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Calumet Specialty can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a minute ago at investing.com         
Calumet posts Q4 loss, revenue beats estimates
Investing News at Macroaxis
a day ago at finance.yahoo.com         
Individual investors who hold 45 percent of Calumet, Inc. gained 3.4, institutions profited as well
Yahoo News
few days ago at www.macroaxis.com         
Disposition of 15037 shares by Stephen Mawer of Calumet Specialty at 17.87 subject to Rule 16b-3
Macroaxis News
six days ago at investors.com         
Calumet Clears Technical Benchmark, Hitting 80-Plus RS Rating
Investors Business Daily at Macroaxis
six days ago at finance.yahoo.com         
Naphthenic Base Oil Strategic Business Report 2024, with Coverage of Major Players including Apar In...
Yahoo News
six days ago at finance.yahoo.com         
Calumet Announces Settlement of its Exchange Offer for any and all of the Outstanding 11.00 percent ...
Yahoo News
six days ago at prnewswire.com         
Calumet Announces Settlement of its Exchange Offer for any and all of the Outstanding 11.00 percent ...
prnewswire News
six days ago at gurufocus.com         
Calumet Announces Settlement of its Exchange Offer for any and all of the Outstanding 11. ...
Gurufocus Stories at Macroaxis
over a week ago at prnewswire.com         
Calumet Announces Expiration and Final Results for its Exchange Offer for any and all of the Outstan...
prnewswire News
over a week ago at gurufocus.com         
Acquisition by Louis Borgmann of 10000 shares of Calumet Specialty at 21.78 subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over a week ago at gurufocus.com         
Calumet Announces Expiration and Final Results for its Exchange Offer for any and all of the ...
Gurufocus Stories at Macroaxis
over a week ago at finance.yahoo.com         
Calumet Announces Expiration and Final Results for its Exchange Offer for any and all of the Outstan...
Yahoo News
over a week ago at www.macroaxis.com         
Disposition of 900 shares by Louis Borgmann of Calumet Specialty at 20.0 subject to Rule 16b-3
Macroaxis News
over a week ago at gurufocus.com         
Calumet to Participate in December 2024 Investor Conferences
Gurufocus Stories at Macroaxis
over two weeks ago at simplywall.st         
Dont Ignore The Insider Selling In Calumet
Simply Wall St News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Calumet Specialty that are available to investors today. That information is available publicly through Calumet media outlets and privately through word of mouth or via Calumet internal channels. However, regardless of the origin, that massive amount of Calumet data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Calumet Specialty news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Calumet Specialty relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Calumet Specialty's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Calumet Specialty alpha.

Calumet Specialty Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Sajkowski Daniel J of 7490 shares of Calumet Specialty subject to Rule 16b-3
09/13/2024
2
Calumet Specialty Products Partners Hits New 1-Year High Should You Buy
10/14/2024
3
Calumet, Inc. to Release Third Quarter 2024 Earnings on November 8, 2024
10/25/2024
4
Disposition of 11111 shares by Gregory Morical of Calumet Specialty at 15.04 subject to Rule 16b-3
10/28/2024
5
Calumet Reports Third Quarter 2024 Results
11/08/2024
6
HC Wainwright Reiterates Buy Rating for Calumet Specialty Products Partners
11/11/2024
7
Disposition of 100000 shares by Straumins Jennifer of Calumet Specialty at 20.05 subject to Rule 16b-3
11/13/2024
8
Disposition of 900 shares by Louis Borgmann of Calumet Specialty at 20.0 subject to Rule 16b-3
11/21/2024
9
Calumet Announces Expiration and Final Results for its Exchange Offer for any and all of the Outstanding 11.00 percent Senior Notes due 2025
11/22/2024
10
Calumet Clears Technical Benchmark, Hitting 80-Plus RS Rating
11/25/2024
11
Disposition of 15037 shares by Stephen Mawer of Calumet Specialty at 17.87 subject to Rule 16b-3
11/27/2024

Additional Tools for Calumet Stock Analysis

When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.